107 related articles for article (PubMed ID: 16954344)
1. Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.
Nasrallah R; Xiong H; Hébert RL
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F278-84. PubMed ID: 16954344
[TBL] [Abstract][Full Text] [Related]
2. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
3. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
[TBL] [Abstract][Full Text] [Related]
5. Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
Krause MP; Riddell MC; Gordon CS; Imam SA; Cafarelli E; Hawke TJ
J Appl Physiol (1985); 2009 May; 106(5):1650-9. PubMed ID: 19246652
[TBL] [Abstract][Full Text] [Related]
6. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
7. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
9. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
10. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause.
Keck M; Romero-Aleshire MJ; Cai Q; Hoyer PB; Brooks HL
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F193-9. PubMed ID: 17389681
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of cyclooxygenase-1 and -2 in the diabetic rat renal medulla.
Nasrallah R; Landry A; Singh S; Sklepowicz M; Hébert RL
Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1068-77. PubMed ID: 12888618
[TBL] [Abstract][Full Text] [Related]
12. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat.
Li J; Chen YJ; Quilley J
J Pharmacol Exp Ther; 2005 Aug; 314(2):818-24. PubMed ID: 15879008
[TBL] [Abstract][Full Text] [Related]
13. Assessment of diabetic nephropathy in the Akita mouse.
Chang JH; Gurley SB
Methods Mol Biol; 2012; 933():17-29. PubMed ID: 22893398
[TBL] [Abstract][Full Text] [Related]
14. Impact of genetic background on nephropathy in diabetic mice.
Gurley SB; Clare SE; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F214-22. PubMed ID: 16118394
[TBL] [Abstract][Full Text] [Related]
15. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
Coe LM; Zhang J; McCabe LR
J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
[TBL] [Abstract][Full Text] [Related]
16. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
17. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
18. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
[TBL] [Abstract][Full Text] [Related]
19. PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.
Hassouneh R; Nasrallah R; Zimpelmann J; Gutsol A; Eckert D; Ghossein J; Burns KD; Hébert RL
Diabetologia; 2016 Jun; 59(6):1318-28. PubMed ID: 26995650
[TBL] [Abstract][Full Text] [Related]
20. Arginase-2 mediates diabetic renal injury.
Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
